Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 791

Results For "ED"

11235 News Found

Eugia Pharma receives USFDA approval for Carboprost Tromethamine Injection
Drug Approval | May 27, 2023

Eugia Pharma receives USFDA approval for Carboprost Tromethamine Injection

The product is expected to be launched in June 2023


Labindia partners with Hamilton Laboratory to launch ‘Labindia Hamilton’
News | May 27, 2023

Labindia partners with Hamilton Laboratory to launch ‘Labindia Hamilton’

Product deliveries scheduled in Q3 of 2023


Lincoln Pharmaceuticals posts FY23 PAT at Rs. 72.90 Cr
News | May 26, 2023

Lincoln Pharmaceuticals posts FY23 PAT at Rs. 72.90 Cr

For Q4 ended FY23, company reported net profit of Rs. 12.56 crore as against net profit of Rs. 11.02 crore in the corresponding period last year


Lupin Diagnostics Launches Satellite Laboratory in Vijayawada
News | May 26, 2023

Lupin Diagnostics Launches Satellite Laboratory in Vijayawada

Continues to Expand its Presence in South India


Mandaviya addresses 76th World Health Assembly
News | May 25, 2023

Mandaviya addresses 76th World Health Assembly

The Global Medical Countermeasures Platform will provide equal access safe, high-quality, cost-effective medical countermeasures to the world


JB Pharma records revenue growth of 22% to Rs. 762 Cr
News | May 25, 2023

JB Pharma records revenue growth of 22% to Rs. 762 Cr

Operating EBITDA increased by 21% to INR 181 crores in Q4 FY23


GenWorks launches FenomPro breath analyser
News | May 25, 2023

GenWorks launches FenomPro breath analyser

Ensures efficient testing of FeNO as it is a simple tool for the diagnosis, screening & monitoring of Asthma patients


Agilent to appeal patent office decision on CRISPR gRNA patents
News | May 23, 2023

Agilent to appeal patent office decision on CRISPR gRNA patents

Agilent respectfully disagrees with the PTAB’s opinion of unpatentability in view of prior art previously considered by the USPTO during its primary examination


Freenome acquires global immunodiagnostics developer Oncimmune
News | May 23, 2023

Freenome acquires global immunodiagnostics developer Oncimmune

Acquisition enhances Freenome's product portfolio, including autoantibody platform with additional biomarkers important in cancer detection